Monday 31 March 2014

April 24 - Application deadline for CCMB Research Day for Trainees

The deadline to submit your application for either a poster or an oral presentation is April 24th.

Abstracts must use the following categories:
1) Objectives
2) Methods
3) Results
4) Conclusions

Abstracts must be formatted as:
- maximum of 300 words, single spaced using 11pt Times New Roman font
- 1" block and justified margins
- All results and conclusions must be stated in the abstract

Submit via email to Jaclyn.Javier@cancercare.mb.ca

April 1 - Haematology/Oncology Regional Grand Rounds

Title: The Cancer Community: Everyone Counts.
Presented by: Dr. Shantanu Banerji, Medical Oncologist
Time: 12:00 - 1:00
Location: CCMB Lecture Theatre
Educational Objectives: Define intra-tumour heterogeneity, appreciate the rationale for exploring tumour heterogeneity

March 31 - Cell Biology Club

Project updates by Landon Wark, Eric Bouchard & Laura Thompson
2:00 - 3:00
CCMB Lecture Theatre

Tuesday 25 March 2014

April 2 - PhD Thesis Defense for Sara Beiggi

Notice of Final PhD Oral Examination for Sara Beiggi
Department of Biochemistry & Medical Genetics
“Epidemiological Study of Chronic Lymphocytic Leukemia (CLL) in the Province of Manitoba, Canada”
DATE: WEDNESDAY, APRIL 2, 2014
TIME: 10:00 A.M.
PLACE: 341 BASIC MEDICAL SCIENCES BLDG.

Wednesday 12 March 2014

March 19 - BMG Departmental Seminar

Presenter: Dr. Versha Banerji, Department of Internal Medicine & Biochemistry and Medical Genetics
Date: Wednesday, March 19, 2014
Time: 12:15 – 1:15 pm
Location: Theatre A “Mezzanine”
Seminar Title: "Inhibiting Nicotinamide phosphoribosyl transferase (NAMPT) to kill Chronic Lymphocytic Leukemia cells"

Monday 3 March 2014

March 6th - Genetic Academic Sessions

Location: Gordon Chown Room, Basement CSB
Research rounds: Thursday, March 6th 3:00 pm – 4:00 pm
Presenter: Yueqin Zhou, PhD candidate
Topic: “Familial ALS with FUS mutations has compromised alternative splicing and autoregulation - a mechanism of rare disease with broad implication?”

After this session, participants will be able to:
Understand the genetics bases of amyotrophic lateral sclerosis (ALS).
Describe the mechanism of FUS autoregulation through alternative splicing.
Discuss the significance of dysregulated FUS autoregulation in ALS-FUS pathogenesis and its therapeutic implication..

This event is an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada